What Is Perimenopause?
Perimenopause is the transitional phase that precedes menopause — the period during which the ovaries gradually reduce their hormonal output and menstrual cycles become irregular. It is not a disease, but a natural biological stage. For many women, it is the most symptomatic phase of the entire menopausal transition.
Perimenopause typically begins in the mid-to-late 40s, though it can start as early as the late 30s in some women. It lasts on average 4–8 years, ending when 12 consecutive months have passed without a period — the point retrospectively defined as menopause.
The term is often used loosely, but clinically it refers specifically to the transition itself, before menopause is confirmed.
Key Points
- Perimenopause begins on average in the mid-to-late 40s and lasts 4–8 years.
- Symptoms are driven by hormonal fluctuation, not simply by declining levels.
- Hot flushes, night sweats, sleep disruption, mood changes, and irregular cycles are the hallmark features.
- Clinical diagnosis is made on symptoms and cycle pattern; blood tests are not required for women over 45.
- Contraception remains necessary until 12 months after the last period.
- Hormone therapy is the most effective treatment for moderate-to-severe vasomotor symptoms.
- Weight gain — particularly visceral fat accumulation — is driven by metabolic changes, not simply lifestyle.
The Hormonal Changes Driving Symptoms
The ovaries contain a finite supply of follicles. As this reserve diminishes, hormonal output becomes erratic. During perimenopause:
- Oestrogen fluctuates dramatically — swinging between unusually high and unusually low levels before eventually settling into the consistently low postmenopausal baseline
- Progesterone declines more steadily, particularly in the years before the final period
- FSH (follicle-stimulating hormone) rises as the pituitary gland attempts to stimulate a diminishing ovarian reserve
- Testosterone declines gradually, affecting libido and energy in some women
This hormonal volatility — not a simple downward progression — is what drives the unpredictability and intensity of perimenopausal symptoms. Oestrogen can surge one week and drop sharply the next.
Common Symptoms
Menstrual Changes
Changes to the menstrual cycle are usually the first perceptible sign of the transition:
- Shorter cycles — the interval between periods shortens as follicular phase length changes
- Heavier or longer periods — anovulatory cycles can cause the uterine lining to thicken more than usual, leading to heavier or prolonged bleeding
- Irregular timing — cycles become unpredictable, with gaps of varying length
- Skipped periods — as the transition progresses, longer gaps occur
- Spotting between periods
New heavy or prolonged bleeding in perimenopause should always be assessed medically to exclude endometrial pathology. See Heavy Periods: When to Seek Help.
Vasomotor Symptoms (Hot Flushes and Night Sweats)
Hot flushes affect roughly 75% of women during the transition. They involve a sudden wave of heat — typically spreading from the chest to the neck and face — often with visible flushing, sweating, and sometimes palpitations. Episodes typically last 2–4 minutes.
Night sweats are nocturnal hot flushes that wake women from sleep, sometimes requiring a change of clothing or bedding.
Vasomotor symptoms typically begin during perimenopause, before periods have stopped, and on average persist for 7 years — though duration is highly variable. For some women they are mild; for others they severely disrupt work, sleep, and relationships.
Sleep Disruption
Poor sleep is among the most common and debilitating perimenopausal complaints. Contributors include:
- Night sweats waking women repeatedly
- Direct hormonal effects on sleep architecture — oestrogen and progesterone both influence slow-wave and REM sleep
- Anxiety and mood disturbance reducing sleep quality independently
- Conditioned insomnia developing over time as wakefulness becomes a learned response
Sleep disruption during perimenopause is not simply a consequence of night sweats. Even women without significant vasomotor symptoms report reduced sleep quality. See Menopause and Sleep: Why Rest Becomes Harder and What Helps for a detailed guide.
Mood and Psychological Changes
The perimenopause represents a genuine window of increased psychological vulnerability:
- Irritability and low frustration tolerance — among the most frequently reported, and least expected, perimenopausal symptoms
- Anxiety — new or worsened, sometimes appearing for the first time in women with no prior history
- Depressed mood — the perimenopausal period carries approximately twice the risk of a new depressive episode compared with the premenopausal years
- Emotional lability — heightened reactivity, tearfulness, low mood that shifts within hours
- “Brain fog” — difficulties with concentration, word-finding, and short-term memory; typically transient and resolving in postmenopause
Women with a prior history of premenstrual dysphoric disorder (PMDD) or postnatal depression are at higher risk of significant perimenopausal mood symptoms.
Weight and Metabolic Changes
Many women notice weight gain — particularly visceral fat accumulation around the abdomen — during perimenopause, even without changes to diet or exercise. This reflects metabolic shifts associated with oestrogen decline:
- Reduced insulin sensitivity
- Changes in fat distribution from subcutaneous to visceral depots
- Reduction in resting metabolic rate
- Changes in appetite-regulating hormones
These metabolic changes have independent cardiovascular and metabolic implications. They are hormonally mediated — not simply a result of ageing or inactivity.
Other Symptoms
| Symptom | Cause |
|---|---|
| Vaginal dryness | Oestrogen-dependent mucosal thinning |
| Reduced libido | Declining oestrogen and testosterone, sleep disruption |
| Joint aches and stiffness | Oestrogen has anti-inflammatory effects on joints |
| Skin changes | Reduced collagen production |
| Hair thinning | Androgen-oestrogen balance shift |
| Palpitations | Vasomotor instability |
| Urinary urgency or frequency | Early genitourinary syndrome of menopause (GSM) |
Diagnosis
Perimenopause is a clinical diagnosis based on age, symptoms, and cycle pattern. For women aged 45 and over with typical symptoms and irregular cycles, no blood tests are required.
Blood tests may be useful when:
- A woman is under 45 and perimenopause is suspected
- Cycles are masked by hormonal contraception
- The clinical picture is atypical or another cause must be excluded (e.g. thyroid disease, hyperprolactinaemia)
- Premature ovarian insufficiency (POI) needs to be confirmed in women under 40
Note that FSH and oestradiol levels fluctuate enormously during perimenopause. A single “normal” result does not exclude the diagnosis, and a single elevated FSH does not confirm it. Testing is rarely necessary for the diagnosis in women over 45.
Treatment Options
Hormone Therapy (HRT / MHT)
Hormone therapy is the most effective treatment for moderate-to-severe vasomotor symptoms and often improves sleep, mood, and genitourinary symptoms as a result. For most healthy women under 60 — or within 10 years of their final period — benefits typically outweigh risks.
Starting hormone therapy during perimenopause (rather than waiting until after menopause) is entirely appropriate if symptoms are significantly impacting quality of life.
Women with a uterus require combined oestrogen-progestogen therapy; those after hysterectomy may use oestrogen alone. Low-dose combined oral contraceptives also provide effective symptom control during perimenopause alongside contraception.
See Hormone Therapy for Menopause: Benefits, Risks, and Who It Suits for a full guide.
Non-Hormonal Options
For women who cannot or choose not to use hormone therapy:
| Treatment | Evidence | Best For |
|---|---|---|
| SSRIs/SNRIs (e.g. venlafaxine, escitalopram) | Moderate — reduces hot flush frequency 40–60% | Vasomotor symptoms; women with comorbid depression |
| Fezolinetant (NK3 receptor antagonist) | Strong — newer non-hormonal option | Vasomotor symptoms — prescription-only |
| Gabapentin | Moderate | Hot flushes; sleep disruption |
| Cognitive behavioural therapy (CBT) | Good | Mood, sleep, and coping with symptoms |
| Local vaginal oestrogen | Excellent | Genitourinary symptoms — safe even with most contraindications to systemic HRT |
Lifestyle
- Regular aerobic and resistance exercise — reduces vasomotor symptoms in some women; critical for cardiovascular, metabolic, and bone health
- Sleep hygiene — consistent schedule, cool bedroom, limit alcohol (which worsens hot flushes and sleep quality)
- Diet — Mediterranean-style pattern, adequate calcium (1,000–1,200 mg/day), vitamin D sufficiency
- Reducing triggers — alcohol, caffeine, hot drinks, and spicy food can worsen hot flushes in some women
- Mindfulness and CBT-based approaches — evidence supports these for perimenopausal mood and sleep symptoms
- Avoid smoking — associated with earlier menopause and worse vasomotor symptoms
When to Seek Medical Assessment
| Symptom | Reason to Seek Care |
|---|---|
| Heavy or prolonged periods | Exclude endometrial pathology; assess for iron deficiency |
| Spotting between periods or after sex | Exclude cervical or endometrial pathology |
| Perimenopause symptoms before 45 | Confirm timing; exclude premature ovarian insufficiency |
| Any symptoms before 40 | Investigate as premature ovarian insufficiency (POI) |
| Severe or rapidly worsening depression | Clinical assessment required — not simply hormonal |
| Symptoms significantly impacting daily function | Discuss treatment options including HRT |
Related Guides
- Menopause: Symptoms, Stages, and What to Expect
- Hormone Therapy for Menopause: Benefits, Risks, and Who It Suits
- Menopause and Sleep: Why Rest Becomes Harder and What Helps
- Heavy Periods: When to Seek Help
- Women’s Health Hub
- Sleep Health Hub
- Depression: Symptoms, Causes, and Treatment
- Anxiety Disorders
- Bone Density and Osteoporosis: What You Need to Know
- Cardiovascular Risk Assessment — Understanding Your Numbers
Educational only; not a substitute for professional medical advice.